“…In addition, bacterial infections for some susceptible populations like diabetics are still problematical, which leads to high rates of disability and mortality . In response, it is an urgent need to develop various advanced approaches to fight against pathogenic bacteria. − Theranostic platforms, integrating both functions of diagnosis and therapy in a single formulation to synchronously achieve target detection, distribution monitoring, therapeutic intervention, and efficacy evaluation, have attracted tremendous attention. , Developing theranostic platforms toward pathogenic bacteria is highly desired to provide more opportunities for precision medicine to meet the practical needs of preventing drug abuse, lowering drug-induced risk, streamlining medication processes, saving healthcare resources, and so forth. − Although tremendous progress has been made in antibacterial theranostic platforms, there still exists plenty of room for improvement in biosafety, accuracy, and efficiency.…”